Search research articles
Contact Us
Filters
Showing results (841-850 of 1,351) with videos related to
Page
of 136
Sort By:
Cell Communication and Signaling : CCS
|
May 9, 2013
Signal transduction in primary human T lymphocytes in altered gravity - results of the MASER-12 suborbital space flight mission
Svantje Tauber, Swantje Hauschild, Claudia Crescio, et al.
Current Biology : CB
|
May 2, 2017
Dendritic Cells Interpret Haptotactic Chemokine Gradients in a Manner Governed by Signal-to-Noise Ratio and Dependent on GRK6
Jan Schwarz, Veronika Bierbaum, Kari Vaahtomeri, et al.
Archives of Gynecology and Obstetrics
|
October 22, 2008
Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine
Elisabeth Barthell, Linn Woelber, Karin Hellner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2019
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAF<sup>V600</sup> mutation-positive metastatic melanoma treated with vemurafenib ± cobimetinib
Karl Lewis, Axel Hauschild, James Larkin, et al.
Plos One
|
April 21, 2026
Detecting apple replant disease in the field - deciphering reasons for local growth depression
Anne-Sophie Wachter, Kristin Hauschild, Benye Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Mirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
Nature
|
April 5, 2019
Nuclear positioning facilitates amoeboid migration along the path of least resistance
Jörg Renkawitz, Aglaja Kopf, Julian Stopp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2010
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma
John M Kirkwood, Paul Lorigan, Peter Hersey, et al.
Drug and Alcohol Dependence Reports
|
January 1, 2024
Prevalence of xylazine among people who inject drugs seeking medical care at a syringe services program clinic: Miami, Florida, 2023
Maia H Hauschild, Peyton V Warp, Hansel E Tookes, et al.
Page
of 136
Search research articles
Search
Showing results (841-850 of 1,351) with videos related to
Sort By:
Page
of 136
Cell Communication and Signaling : CCS
|
May 9, 2013
Signal transduction in primary human T lymphocytes in altered gravity - results of the MASER-12 suborbital space flight mission
Svantje Tauber, Swantje Hauschild, Claudia Crescio, et al.
Current Biology : CB
|
May 2, 2017
Dendritic Cells Interpret Haptotactic Chemokine Gradients in a Manner Governed by Signal-to-Noise Ratio and Dependent on GRK6
Jan Schwarz, Veronika Bierbaum, Kari Vaahtomeri, et al.
Archives of Gynecology and Obstetrics
|
October 22, 2008
Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine
Elisabeth Barthell, Linn Woelber, Karin Hellner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2019
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAF<sup>V600</sup> mutation-positive metastatic melanoma treated with vemurafenib ± cobimetinib
Karl Lewis, Axel Hauschild, James Larkin, et al.
Plos One
|
April 21, 2026
Detecting apple replant disease in the field - deciphering reasons for local growth depression
Anne-Sophie Wachter, Kristin Hauschild, Benye Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Mirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
Nature
|
April 5, 2019
Nuclear positioning facilitates amoeboid migration along the path of least resistance
Jörg Renkawitz, Aglaja Kopf, Julian Stopp, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2010
Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma
John M Kirkwood, Paul Lorigan, Peter Hersey, et al.
Drug and Alcohol Dependence Reports
|
January 1, 2024
Prevalence of xylazine among people who inject drugs seeking medical care at a syringe services program clinic: Miami, Florida, 2023
Maia H Hauschild, Peyton V Warp, Hansel E Tookes, et al.
Page
of 136